BioSpace News Archive

Business

Novartis Exercises Option for Akcea Lipoprotein Treatment for CVD Patients

Months after Akcea Therapeutics unveiled positive mid-stage data that showed its therapy reduced elevated levels of lipoprotein(a) in patients with cardiovascular disease (CVD), Swiss pharma giant Novartis exercised its option to take license the therapy and take it through late-stage studies.

February 25, 2019

·

2 min read

·

Alex Keown

Business

More CRISPR Scandal News: Could the Babies Have Modified Intelligence? Did the Government Fund the Research?

More news has come from China about the two babies born following He Jiankui’s experiment using CRISPR to make the children resistant to HIV while they were still embryos. Now, there is some evidence to suggest that the two infants could develop genetically-enhanced brains.

February 25, 2019

·

3 min read

·

Alex Keown

Business

FDA and Flatiron Health Expand Real-World Data Cancer Research Collaboration

Roche’s Flatiron Health and the U.S. Food and Drug Administration’s Information Exchange and Data Transformation (INFORMED) Program expanded a two-year-old collaboration agreement.

February 25, 2019

·

3 min read

·

Alex Keown

Sponsored | Five Unique Problems That MES Can Address for Cell and Gene Therapy Manufacturing

Together with its Körber partner companies, Werum is working on solutions that help streamline the complex cell and gene therapy workflows and enable delivery at scale of these critical, life-saving and personalized medicines.

February 25, 2019

·

2 min read

·

Werum IT Solutions America, Inc.

Business

Texas Makes Move to Lure Companies to the State to Enhance Its Biotech Industry

During his two years in office, former Texas Secretary of State Rolando Pablos flexed the muscles of his office to make recruiting biotech and pharma companies a priority.

February 25, 2019

·

3 min read

·

Alex Keown

Pharming announces abstract presented at the American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting and sponsorship of the AAAAI Foundation Michael M. Frank, MD, FAAAI Lectureship

Pharming Group N.V. announced that an abstract was presented this week at the American Academy of Allergy, Asthma & Immunology Annual Meeting in San Francisco, CA.

February 25, 2019

·

8 min read

Deals

Microbix Announces Issuance of Stock Options - February 25, 2019

Microbix Biosystems Inc., an innovator of biological products and technologies, announces the issuance of stock options under its shareholder-approved 2018 stock option plan, as part of its compensation programs to incentivize and retain its board of directors, executives, and managers.

February 25, 2019

·

4 min read

Pharm Country

Soligenix Corporate Presentation Webcast Recording

An updated webcast of the Soligenix Corporate Presentation, given by Dr. Christopher J. Schaber, President and CEO, is available on the Company website. To listen and view the presentation, please visit www.soligenix.com.

February 25, 2019

·

3 min read

Deals

Ipsen Strikes Deal to Acquire Clementia for $1.31 Billion, Sends Stocks Soaring

This morning, Ipsen said it entered into an agreement with Clementia will help the company continue its transformation that is part of a key strategic objective to accelerate its rare disease pipeline.

February 25, 2019

·

2 min read

·

Alex Keown

Lumasiran was granted priority review status by FD

Policy

Karyopharm Plunges After FDA Briefing Materials Raise Questions About Safety of Multiple Myeloma Drug

The FDA noted some concerns over the drug’s safety profile. Treatment with selinexor is associated with significant toxicity, the agency noted in its materials.

February 25, 2019

·

2 min read

·

Alex Keown